N Y Lashch, A A Ashikhmina, M I Kislaya, L A Filatova
{"title":"[Hormonal contraception methods and multiple sclerosis].","authors":"N Y Lashch, A A Ashikhmina, M I Kislaya, L A Filatova","doi":"10.17116/jnevro202512501124","DOIUrl":null,"url":null,"abstract":"<p><p>Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease that is diagnosed in women twice as often as in men, especially in groups of family cases and at the age of up to 35 years. Among patients diagnosed with MS, there are many young and middle-aged women who are planning a pregnancy in the future and want to protect themselves from unwanted pregnancy at the present time. Also, for patients with MS, the importance of reducing the frequency of abortions is obvious. The question arises - what drugs are safe, convenient and effective for this group of patients. Moreover, one of the modern hypotheses of treatment in relation to reducing relapses and progression of MS is the use of estrogen. Therefore, the strategy of choice may be the use of estrogen-containing oral contraceptives as means that provide effective protection against pregnancy and at the same time, possibly, affect the course of the underlying disease in a positive way.</p>","PeriodicalId":56370,"journal":{"name":"Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova","volume":"125 1","pages":"24-30"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17116/jnevro202512501124","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease that is diagnosed in women twice as often as in men, especially in groups of family cases and at the age of up to 35 years. Among patients diagnosed with MS, there are many young and middle-aged women who are planning a pregnancy in the future and want to protect themselves from unwanted pregnancy at the present time. Also, for patients with MS, the importance of reducing the frequency of abortions is obvious. The question arises - what drugs are safe, convenient and effective for this group of patients. Moreover, one of the modern hypotheses of treatment in relation to reducing relapses and progression of MS is the use of estrogen. Therefore, the strategy of choice may be the use of estrogen-containing oral contraceptives as means that provide effective protection against pregnancy and at the same time, possibly, affect the course of the underlying disease in a positive way.
期刊介绍:
Одно из старейших медицинских изданий России, основанное в 1901 году. Создание журнала связано с именами выдающихся деятелей отечественной медицины, вошедших в историю мировой психиатрии и неврологии, – С.С. Корсакова и А.Я. Кожевникова.
Широкий диапазон предлагаемых журналом материалов и разнообразие форм их представления привлекают внимание научных работников и врачей, опытных и начинающих медиков, причем не только неврологов и психиатров, но и специалистов смежных областей медицины.